Justin Bowers
Stock Analyst at Deutsche Bank
(1.89)
# 3,115
Out of 5,182 analysts
41
Total ratings
37.5%
Success rate
4.36%
Average return
Main Sectors:
Stocks Rated by Justin Bowers
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| WAT Waters | Maintains: Hold | $370 → $330 | $330.98 | -0.30% | 5 | Mar 25, 2026 | |
| MEDP Medpace Holdings | Maintains: Hold | $270 → $430 | $520.00 | -17.31% | 3 | Jul 23, 2025 | |
| IQV IQVIA Holdings | Maintains: Buy | $270 → $265 | $175.28 | +51.19% | 2 | Nov 1, 2024 | |
| FTRE Fortrea Holdings | Maintains: Hold | $28 → $23 | $9.59 | +139.83% | 3 | Aug 20, 2024 | |
| CON Concentra Group Holdings Parent | Initiates: Buy | $29 | $22.75 | +27.47% | 1 | Aug 19, 2024 | |
| TXG 10x Genomics | Downgrades: Hold | $55 → $25 | $24.80 | +0.81% | 3 | Jul 10, 2024 | |
| RGEN Repligen | Upgrades: Buy | $180 → $155 | $131.03 | +18.29% | 2 | Jun 26, 2024 | |
| TMO Thermo Fisher Scientific | Maintains: Buy | $600 → $610 | $527.22 | +15.70% | 3 | Apr 25, 2024 | |
| TECH Bio-Techne | Maintains: Buy | $85 → $82 | $58.66 | +39.79% | 2 | Apr 18, 2024 | |
| AVTR Avantor | Maintains: Hold | $23 → $25 | $8.20 | +204.88% | 3 | Apr 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $23 → $17 | $3.28 | +418.29% | 3 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $280 → $300 | $113.06 | +165.35% | 2 | Jul 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $310 → $275 | $198.61 | +38.46% | 2 | Apr 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $250 | $267.93 | -6.69% | 1 | Dec 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $350 → $290 | $179.31 | +61.73% | 1 | Jul 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $42 → $46 | $16.38 | +180.83% | 5 | May 10, 2021 |
Waters
Mar 25, 2026
Maintains: Hold
Price Target: $370 → $330
Current: $330.98
Upside: -0.30%
Medpace Holdings
Jul 23, 2025
Maintains: Hold
Price Target: $270 → $430
Current: $520.00
Upside: -17.31%
IQVIA Holdings
Nov 1, 2024
Maintains: Buy
Price Target: $270 → $265
Current: $175.28
Upside: +51.19%
Fortrea Holdings
Aug 20, 2024
Maintains: Hold
Price Target: $28 → $23
Current: $9.59
Upside: +139.83%
Concentra Group Holdings Parent
Aug 19, 2024
Initiates: Buy
Price Target: $29
Current: $22.75
Upside: +27.47%
10x Genomics
Jul 10, 2024
Downgrades: Hold
Price Target: $55 → $25
Current: $24.80
Upside: +0.81%
Repligen
Jun 26, 2024
Upgrades: Buy
Price Target: $180 → $155
Current: $131.03
Upside: +18.29%
Thermo Fisher Scientific
Apr 25, 2024
Maintains: Buy
Price Target: $600 → $610
Current: $527.22
Upside: +15.70%
Bio-Techne
Apr 18, 2024
Maintains: Buy
Price Target: $85 → $82
Current: $58.66
Upside: +39.79%
Avantor
Apr 18, 2024
Maintains: Hold
Price Target: $23 → $25
Current: $8.20
Upside: +204.88%
Aug 8, 2023
Maintains: Buy
Price Target: $23 → $17
Current: $3.28
Upside: +418.29%
Jul 14, 2023
Maintains: Buy
Price Target: $280 → $300
Current: $113.06
Upside: +165.35%
Apr 27, 2023
Maintains: Buy
Price Target: $310 → $275
Current: $198.61
Upside: +38.46%
Dec 14, 2022
Initiates: Hold
Price Target: $250
Current: $267.93
Upside: -6.69%
Jul 14, 2022
Maintains: Buy
Price Target: $350 → $290
Current: $179.31
Upside: +61.73%
May 10, 2021
Maintains: Buy
Price Target: $42 → $46
Current: $16.38
Upside: +180.83%